Understanding Arrhythmogenic Cardiomyopathy and its Treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with Arrhythmogenic Cardiomyopathy (ACM) at the First Affiliated Hospital of Xi'an Jiaotong University and other centers. It aims to collect clinical data and biological samples from patients with various ACM phenotypes. By establishing a disease cohort and conducting long-term follow-ups, the study will explore the characteristics, progression, clinical features, natural course, and long-term prognosis of ACM.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>18 years old.
* The diagnosis of ACM was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing.
* Patients or their families agreed to participate in the study and authorized informed consent.

Exclusion Criteria:

* Incomplete clinical data.
* Do not agree to the inclusion or refuse to authorize the informed consent.

Where it's running

• First Affiliated Hospital of Xi'an Jiantong University
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Principal investigator: Yang Yan — First Affiliated Hospital Xi'an Jiaotong University
• Study coordinator: Yang Yan
• Email: yangyan3@xjtu.edu.cn
• Phone: +86.29.85323869

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• S-ICD Eligibility Over Time in Arrhythmogenic Cardiomyopathy

  This study checks whether adults with arrhythmogenic cardiomyopathy stay eligible for a subcutaneous ICD over 18 months.

  Recruiting University of Sao Paulo · São Paulo, São Paulo · NCT07849764

• T1 mapping to characterize heart tissue in common heart diseases

  This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing, Beijing Municipality · NCT07354646

• Assessing patient characteristics and clinical course for those with PKP2-ACM

  This study looks at the experiences and health changes of people with PKP2-ACM over time to better understand the condition and its impact on their lives.

  Recruiting at 6 sites Lexeo Therapeutics · Redwood City, California and 5 other locations · NCT06976606

• Atorvastatin 80 mg to slow progression of arrhythmogenic cardiomyopathy

  This trial will try daily high-dose atorvastatin (80 mg) versus placebo in adults with arrhythmogenic cardiomyopathy to see if it prevents right ventricular functional decline and related electrical and structural worsening.

  Recruiting at 4 sites Phase 2 Centro Cardiologico Monzino · Pavia, PV and 4 other locations · NCT06922994

• Identifying patients with cardiomyopathy for potential heart transplantation

  This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Emilia-Romagna/Bologna and 2 other locations · NCT06813443

• Predicting Ventricular Tachycardia Events in Patients with Non-Ischemic Cardiomyopathy

  This study is trying to see if certain heart imaging tests can help predict the risk of dangerous heart rhythms and sudden cardiac death in people with non-ischemic cardiomyopathy.

  Recruiting at 4 sites Centro Medico Teknon · Milan, Italy and 3 other locations · NCT06730464

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.